In a cohort of 2,399 patients with SLE, 55% had low C3 levels and 47% had low C4 levels, and neuropsychiatric manifestations, including seizure, psychosis, and stroke, were significantly associated with both low C3 and C4 levels [11]. This evidence concerns the gene C3 and systemic lupus erythematosus.